TY - JOUR
T1 - A good antisense molecule is hard to find
AU - Branch, Andrea D.
N1 - Funding Information:
I thank J. L. Walewski and D. D. Stump (Mount Sinai School of Medicine), N. V. Bergasa (Beth Israel Medical Center), K. K. Willis (Academic Press), A. M. Krieg (University of Iowa), C. A. Stein (Columbia University), and C. E Bennett (Isis Pharmaceuticals) for insights and T. Lefkowitz for assistance. This work has been supported by the NIDDK (grant PO1DK50795, project 2, and grant ROIDK52071) and the Liver Transplantation Research Fund (Department of Surgery, Mount Sinai School of Medicine).
PY - 1998/2
Y1 - 1998/2
N2 - Antisense molecules and ribozymes capture the imagination with their promise of rational drug design and exquisite specificity. However, they are far more difficult to produce than was originally anticipated, and their ability to eliminate the function of a single gene has never been proven. Furthermore, a wide variety of unexpected non-antisense effects have come to light. Although some of these side effects will almost certainly have clinical value, they make it hard to produce drugs that act primarily through true antisense mechanisms and complicate the use of antisense compounds as research reagents. To minimize unwanted non-antisense effects, investigators are searching for antisense compounds and ribozymes whose target sites are particularly vulnerable to attack. This is a challenging quest.
AB - Antisense molecules and ribozymes capture the imagination with their promise of rational drug design and exquisite specificity. However, they are far more difficult to produce than was originally anticipated, and their ability to eliminate the function of a single gene has never been proven. Furthermore, a wide variety of unexpected non-antisense effects have come to light. Although some of these side effects will almost certainly have clinical value, they make it hard to produce drugs that act primarily through true antisense mechanisms and complicate the use of antisense compounds as research reagents. To minimize unwanted non-antisense effects, investigators are searching for antisense compounds and ribozymes whose target sites are particularly vulnerable to attack. This is a challenging quest.
UR - http://www.scopus.com/inward/record.url?scp=0032004967&partnerID=8YFLogxK
U2 - 10.1016/S0968-0004(97)01155-9
DO - 10.1016/S0968-0004(97)01155-9
M3 - Article
C2 - 9538686
AN - SCOPUS:0032004967
SN - 0968-0004
VL - 23
SP - 45
EP - 50
JO - Trends in Biochemical Sciences
JF - Trends in Biochemical Sciences
IS - 2
ER -